| Literature DB >> 29605674 |
Khanchuila Shingnaisui1, Tapan Dey2, Prasenjit Manna3, Jatin Kalita4.
Abstract
ETHNOPHARMACOLOGICAL RELEVANCE: Houttuynia cordata Thunb. (Family: Saururaceae) is an herbaceous perennial plant that grows in moist and shady places. The plant is well known among the people of diverse cultures across Japan, Korea, China and North-East India for its medicinal properties. Traditionally the plant is used for its various beneficial properties against inflammation, pneumonia, severe acute respiratory syndrome, muscular sprain, stomach ulcer etc. Oxidative stress and inflammation were found to be linked with most of the diseases in recent times. Many ancient texts from Chinese Traditional Medicine, Ayurveda and Siddha, and Japanese Traditional medicine have documented the efficacy of H. cordata against oxidative stress and inflammation. AIM OF THE STUDY: This review aims to provide up-to-date and comprehensive information on the efficacy of H. cordata extracts as well as its bioactive compounds both in vitro and in vivo, against oxidative stress and inflammationEntities:
Keywords: Houttuynia cordata Thunb; Inflammation; Oxidative stress; Therapy
Mesh:
Substances:
Year: 2018 PMID: 29605674 PMCID: PMC7127360 DOI: 10.1016/j.jep.2018.03.038
Source DB: PubMed Journal: J Ethnopharmacol ISSN: 0378-8741 Impact factor: 4.360
Inhibition of inflammation by different solvent extracts H. cordata in vivo and in vitro models.
| Afzelin | 50,100,200 mg/kg | None | LPS (40 μg·kg1) /D-galactosamine (800 mg·kg1) | Mice | 5 h | 200 mg/kg | Afzelin | ( |
| Ethanol (100%) | 0.1,0.5,1% | None | LTA(1 µg/ml) | RT-7 | 24hrs | 0.5% | Not mentioned | ( |
| Ethanol (80%) | 400,600,1000 mg/kg Per day | None | Oxaliplatin (6 mg/kg) | Male Sprague Dawley rat (Th17 and Tregs cells) | 15 days | 1000 mg/kg/day | Not mentioned | ( |
| Becatamide | 0,0.05,0.25,0.5 µm | NS-398 | None | Swiss Webster mice | 10 min | 0.25 µm | Houttuynamide A | ( |
| Ethanol (70%) | 30, 100, 300 µg/ml 100, 400 mg/kg | Dexomethasone and 2-Amino− 5,6-dihydro− 6-methyl-4H− 1,3-thiazine hydrochloride (AMT) | LPS | A549, MH-S and Mouse | 16 h | 100 mg/kg | Quercitrin, Hyperoside, Afzelin | ( |
| Polysaccharides | 40,80,160 mg/kg | Dexomethasone | LPS | BALB/cA mice | 24 h | 40 mg/kg | Not mentioned | ( |
| Polysaccharides | 1, 10, and 100 μg/ml | Dexomethasone | LPS | Macrophage | 24 h | 10 μg/ml | Not mentioned | ( |
| Essential oil (Sodium houttuyfonate and 2 undecanone) | 0.1, 1, 10, 20 μg/ml | None | LPS (1 µg/ml) | RAW 264.7 | 24hrs | µg/ml | Sodium houttuyfonate | ( |
| Essential oil (Sodium houttuyfonate and 2-Undecanone) | 100,200,400 mg/kg | Aspirin | Xylene | Mouse | 30 min | 200 mg/kg | sodium houttuyfonate | ( |
| Ethyl acetate | 25,50,100,200 μg/ml | None | LPS(1 µg/ml) | RAW 264.7 | 20hrs | 25 µg/ml | Chlorogenic acid, hyperoside, quercitrin | ( |
| Aqueous | 1 and 2 g/L | None | Acetaminophen (350 mg/kg body weight) | BALB/cA mice | 4 weeks | 2 g/L | Not mentioned | ( |
| Ethanol | 0.05,0.1,0.2, mg/ml | None | PMA + Ca+ ionophore (A23187) | HMC-1 | 5hrs | 0.2 mg/ml | Not mentioned | ( |
| Volatile oil | 1,10,100,1000 μg/ml | None | LPS | Mouse peritoneal macrophage | 24hrs | 100 μg/ml | 2-undecane, n-Decanoic acid, Hexadecanoic acid- methyl ester, 1-Octadecanol, Phytol | ( |
| Volatile oil | 20,40 mg/kg | Dexamethasone | Xylene, Formaldehyde, Carrageenan | Mouse | 7days | 20 mg/kg | 2-undecane, n-Decanoic acid, Hexadecanoic acid- methyl ester, 1-Octadecanol, Phytol | ( |
| Essential oil | 0.01, 0.1, 1, 10, 100 µg/ml | NS- 398 | LPS(1 µg/ml) | Mouse peritoneal macrophage | 24hrs | 10 µg/ml | Not mentioned | ( |
| Hot water | 45, 150, 450 μg/ml | Acyclovir | HSV-2 | HeLa 229 | 6,12,24hrs | 450 μg/ml | quercetin, quercitrin or isoquercitrin, | ( |
| Supercritical solution dissolved in soyabean oil | 65,200 mg/kg | Dexomethasone/ Indomethacin | Carrageenan (1 ml) | Male ICR mice | 1hrs | 200 mg/kg | Not mentioned | ( |
| Supercritical solution dissolved in soyabean oil | 0.001, 0.01, 0.1,1% | None | LPS(2.5 µg/ml) | RAW 264.7 | 24hrs | 0.01% | Not mentioned | ( |
| Sodium houttuyfonate | 60, 120 mg/kg | None | C-BSA | BALB/cMice | 66days | 120 mg/kg | Sodium houttuyfonate | ( |
| Aqueous | 0.5 – 3 g/kg | None | DNP-BSA | ICR Mouse | 2 h | 0.5 g/kg | Not mentioned | ( |
| Aqueous | 1, 10, 20 µg/ml | None | DNP-BSA | RBL-2H3 | 30 min | 1 µg/ml | Not mentioned | ( |
Fig. 1Schematic diagram indicates anti inflammation mechanism of H. cordata in vitro.
Fig. 2Schematic diagram indicates anti inflammation mechanism of H. cordata in vivo.
Inhibition of oxidative stress by different solvent extracts of H. cordata in vivo and in vitro models.
| Afzelin | 50,100,200 mg/kg | None | LPS/D galactosamine | Mice | 1 h | 200 mg/kg | Afzelin | ( |
| Ethanol | 100,200,400 mg/kg | Glibenclamide | Streptozotocin | Albino rat | 7, 14, 21 days | 200 mg/kg | Quercetin | ( |
| 50% Ethanol | 50 µg/ml | None | Palmitate | HAECS | 3 h | 50 µg/ml | chlorogenic acid, rutin, and quercitrin, | ( |
| Aqueous | 1, 2 g/L | None | acetaminophen | BALB/cA mice | 4 weeks | 2 g/L | Not mentioned | ( |
| Methanol | 50,100,200,400 mg/kg | Silymarin | Carbon tetrachloride | Mice | 7 weeks | 200 mg/kg | Not mentioned | ( |
| 50% Methanol | 25,50,100 μg/ml | None | H2O2 | Human peripheral blood lymphocytes | 30 mins | 25 µg/ml | Quercitin, Myricetin, Kaempferol | ( |
| 80% Methanol | 500,1000 mg/kg/day (Pharmacologically/ Therapeutically irrelevant) | None | Gentamicin sulphate | Sprague Dawley rat | 12 days | 500 mg/kg/day | Not mentioned | ( |
| Ethyl acetate | 250,500,1000 mg/kg (Pharmacologically/ Therapeutically irrelevant) | None | Carbon tetrachloride | Kunming Mice | 8days | 500 mg/kg | Quercitrin, quercetin, hyperoside | ( |
| Aqueous | 1, 10, 20 µg/ml | None | DNP-BSA | RBL-2H3 | 30 mins | 1 µg/ml | Not mentioned | ( |
| Aqueous | 1 g/10 ml/kg | None | Bleomycin | Male Wistar rats | 5 weeks | 1 g/10 ml/kg | Not mentioned | ( |
| Aqueous | 0, 2, 5% | None | Oxidized Fried Oil | Sprague Dawley rat | 28 days | 2% | Not mentioned | ( |
Fig. 3Schematic diagram indicates anti oxidative mechanism of H. cordata in vitro.
Fig. 4Schematic diagram indicates anti oxidative mechanism of H. cordata in vivo.